Peake’s bill, which is based on Minnesota’s law, includes plans for strict controls over the manufacturing process as well as systems for tracking the drug as it’s grown, processed, stored and transferred. Local and state law enforcement would have real-time access to the information as well as daily updates on sales.
As under current law, patients would have to provide a doctor’s certification to join the state program.
The bill faces an uncertain future, however, as Gov. Nathan Deal has said he does not support it and a special commission the governor created recommended against creating a Georgia-based manufacturing program. Recent polling, however, suggests a vast majority of Georgians support the idea.